📣 VC round data is live. Check it out!

SKAN Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for SKAN Group and similar public comparables like Haier Biomedical, Savaria, Anbio Biotechnology, Staar Surgical and more.

SKAN Group Overview

About SKAN Group

SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, and transfer systems. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.


Founded

1968

HQ

Switzerland

Employees

1.5K

Website

skan.com

Financials (LTM)

Revenue: $454M
EBITDA: $57M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

SKAN Group Financials

SKAN Group reported last 12-month revenue of $454M and EBITDA of $57M.

In the same LTM period, SKAN Group generated $349M in gross profit, $57M in EBITDA, and $29M in net income.

Revenue (LTM)


SKAN Group P&L

In the most recent fiscal year, SKAN Group reported revenue of $424M and EBITDA of $49M.

SKAN Group is profitable as of last fiscal year, with gross margin of 77%, EBITDA margin of 12%, and net margin of 5%.

See analyst estimates for SKAN Group
LTMLast FY202320242025202620272028
Revenue$454M$424M$407M$460M$424M
Gross Profit$349M$326M$306M$338M$326M
Gross Margin77%77%75%74%77%
EBITDA$57M$49M$58M$76M$45M
EBITDA Margin13%12%14%17%11%
EBIT Margin9%8%12%12%8%
Net Profit$29M$22M$33M$49M$21M
Net Margin6%5%8%11%5%
Net Debt-$41M---

Financial data powered by Morningstar, Inc.

SKAN Group Stock Performance

SKAN Group has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


SKAN Group's stock price is $63.98.

SKAN Group share price increased by 0.7% in the last 30 days, and decreased by 29.9% in the last year.

SKAN Group has an EPS (earnings per share) of $0.99.

See more trading valuation data for SKAN Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B2.0%0.7%18.3%-29.9%$0.99

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

SKAN Group Valuation Multiples

SKAN Group trades at 3.3x EV/Revenue multiple, and 25.9x EV/EBITDA.

See NTM and 2027E valuation multiples for SKAN Group

EV / Revenue (LTM)


SKAN Group Financial Valuation Multiples

As of June 4, 2026, SKAN Group has market cap of $1B and EV of $1B.

SKAN Group has a P/E ratio of 49.3x.

LTMLast FY202320242025202620272028
EV/Revenue3.3x3.5x3.7x3.2x3.5x
EV/EBITDA25.9x30.5x25.7x19.6x32.9x
EV/EBIT38.1x46.0x30.9x26.3x46.0x
EV/Gross Profit4.3x4.6x4.9x4.4x4.6x
P/E49.3x64.8x43.0x29.1x69.5x
EV/FCF(158.2x)64.0x(43.9x)(164.8x)64.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified SKAN Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

SKAN Group Margins & Growth Rates

SKAN Group grew revenue by 18% and EBITDA by 42% in the last fiscal year.

In the most recent fiscal year, SKAN Group reported gross margin of 77%, EBITDA margin of 12%, and net margin of 5%.

See estimated margins and future growth rates for SKAN Group

SKAN Group Margins

Last FY202420252026202720282029
Gross Margin77%74%77%77%
EBITDA Margin12%17%11%14%
EBIT Margin8%12%8%10%
Net Margin5%11%5%8%
FCF Margin5%(2%)5%(11%)

SKAN Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth18%13%(8%)18%
Gross Profit Growth17%11%(3%)17%
EBITDA Growth42%31%(40%)53%
EBIT Growth51%18%(43%)51%
Net Profit Growth74%47%(58%)87%
FCF Growth(330%)(73%)(357%)(330%)

Data powered by FactSet, Inc. and Morningstar, Inc.

SKAN Group Operational KPIs

SKAN Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

SKAN Group's Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

SKAN Group's Rule of X is 59% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for SKAN Group
LTMLast FY202320242025202620272028
Rule of 4030%32%---
Bessemer Rule of X56%59%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-1%1%1%1%
G&A Expenses to Revenue-5%4%4%5%
Opex to Revenue-69%63%61%69%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

SKAN Group Competitors

SKAN Group competitors include Haier Biomedical, Savaria, Anbio Biotechnology, Staar Surgical, Vitrolife, El.En. Group, Nihon Kohden, Poly Medicure, Nolato and Weigao Group.

Most SKAN Group public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Haier Biomedical3.6x3.5x21.3x21.2x
Savaria2.4x2.3x11.6x11.2x
Anbio Biotechnology162.7x-244.0x-
Staar Surgical3.9x4.6x23.7x67.3x
Vitrolife3.9x3.9x13.4x13.1x
El.En. Group1.8x1.8x11.9x11.4x
Nihon Kohden0.9x0.9x7.8x8.1x
Poly Medicure6.8x6.6x22.9x27.5x

This data is available for Pro users. Sign up to see all SKAN Group competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About SKAN Group

When was SKAN Group founded?SKAN Group was founded in 1968.
Where is SKAN Group headquartered?SKAN Group is headquartered in Switzerland.
How many employees does SKAN Group have?As of today, SKAN Group has over 1K employees.
Who is the CEO of SKAN Group?SKAN Group's CEO is Thomas Huber.
Is SKAN Group publicly listed?Yes, SKAN Group is a public company listed on SIX Swiss Exchange.
What is the stock symbol of SKAN Group?SKAN Group trades under SKAN ticker.
When did SKAN Group go public?SKAN Group went public in 2021.
Who are competitors of SKAN Group?SKAN Group main competitors include Haier Biomedical, Savaria, Anbio Biotechnology, Staar Surgical, Vitrolife, El.En. Group, Nihon Kohden, Poly Medicure, Nolato, Weigao Group.
What is the current market cap of SKAN Group?SKAN Group's current market cap is $1B.
What is the current revenue of SKAN Group?SKAN Group's last 12 months revenue is $454M.
What is the current revenue growth of SKAN Group?SKAN Group revenue growth (NTM/LTM) is 17%.
What is the current EV/Revenue multiple of SKAN Group?Current revenue multiple of SKAN Group is 3.3x.
What is the current EBITDA of SKAN Group?SKAN Group's last 12 months EBITDA is $57M.
What is SKAN Group's EBITDA margin?SKAN Group's last 12 months EBITDA margin is 13%.
What is the current EV/EBITDA multiple of SKAN Group?Current EBITDA multiple of SKAN Group is 25.9x.
What is the current FCF of SKAN Group?SKAN Group's last 12 months FCF is ($9M).
What is SKAN Group's FCF margin?SKAN Group's last 12 months FCF margin is (2%).
What is the current EV/FCF multiple of SKAN Group?Current FCF multiple of SKAN Group is (158.2x).
How many companies SKAN Group has acquired to date?SKAN Group hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies SKAN Group has invested to date?SKAN Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to SKAN Group

Lists including SKAN Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial